This resulted in 515 patients for the analysis: 18 with a dMMR tumour (3.5%), of which 13 patients with a dMMR tumour caused by hypermethylation of the MLH1 promoter, and 497 patients with a pMMR tumour. The gene discussed is MLH1; the disease is neoplasm.